|
Volumn 23, Issue SUPPL. 2, 2002, Pages
|
Quetiapine versus clozapine: A preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease
a a b a c b a c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
DOPAMINE;
LEVODOPA;
QUETIAPINE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DOPAMINERGIC SYSTEM;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
HYPOTENSION;
MALE;
MEDICAL ASSESSMENT;
MENTAL DISEASE;
PARKINSON DISEASE;
PATIENT MONITORING;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SCORING SYSTEM;
SOMNOLENCE;
TREATMENT OUTCOME;
AGED;
AGED, 80 AND OVER;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DIBENZOTHIAZEPINES;
DISEASE PROGRESSION;
DOPAMINE AGONISTS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
PSYCHOSES, SUBSTANCE-INDUCED;
|
EID: 0036756967
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s100720200084 Document Type: Article |
Times cited : (64)
|
References (7)
|